Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
FDA distinguishes supplements from medical foods; super fruits are not drugs, FA explains; Sunland resumes production; Bayer voluntarily nixes Alka-Seltzer claims; FDA cites inflammation as drug claim; three Florida supplement makers warned for drug claims; and FDA warns Michigan e-commerce firm on claims.
You may also be interested in...
FDA Suspension Authority Limits Peanut Recall, But FSMA Remains Grounded
In a series of interviews, food safety experts weigh in on why the food and nutritional products industry still has work to do with the Food Safety Modernization Act not yet implemented, as illustrated by the recent salmonella contamination of peanut ingredients from Sunland Inc.
Bayer Alka-Seltzer Plus Ad Modifications Not Sufficient, NAD Decides
Bayer has assured the National Advertising Division of the Council of Better Business Bureaus it immediately discontinued certain parity claims made for Alka-Seltzer Plus Cold Medicine after NAD decided the modified advertising still was problematic.
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.